Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study

Objective The effectiveness and safety of sirolimus for SLE treatment have been shown in some uncontrolled studies. However, a comparison of sirolimus with other classic immunosuppressants has not been reported. We conducted the study to compare the effectiveness and safety of sirolimus versus tacro...

Full description

Bibliographic Details
Main Authors: Xiaofeng Zeng, Qian Wang, Jiuliang Zhao, Xinping Tian, Hongbin Li, Mengtao Li, Yan Zhao, Hui Luo, Yanhong Wang, Xiaofeng Li, Pingting Yang, Xinwang Duan, Yongfei Fang, Hongfeng Zhang, Liying Peng, Chanyuan Wu
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/9/1/e000617.full

Internet

https://lupus.bmj.com/content/9/1/e000617.full

Similar Items